Education
About Us
Working with TipRanks
Follow Us
Organovo Holdings Inc (ONVO)
NASDAQ:ONVO
RESEARCH TOOLSreports
ONVO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.56 - $21.96
Previous CloseN/A
Volume81.09K
Average Volume (3M)N/A
Market Cap
$3.17M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.81
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-10.35
Shares Outstanding1,701,801
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)46.33
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Organovo Holdings News
ONVO FAQ
What was Organovo Holdings Inc’s price range in the past 12 months?
Organovo Holdings Inc lowest stock price was $1.56 and its highest was $21.96 in the past 12 months.
What is Organovo Holdings Inc’s market cap?
Organovo Holdings Inc’s market cap is $3.17M.
When is Organovo Holdings Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Organovo Holdings Inc’s earnings last quarter?
Currently, no data Available
Is Organovo Holdings Inc overvalued?
According to Wall Street analysts Organovo Holdings Inc’s price is currently Overvalued.
Does Organovo Holdings Inc pay dividends?
Organovo Holdings Inc does not currently pay dividends.
What is Organovo Holdings Inc’s EPS estimate?
Organovo Holdings Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Organovo Holdings Inc have?
Organovo Holdings Inc has 1,701,801 shares outstanding.
What happened to Organovo Holdings Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Organovo Holdings Inc?
Currently, no hedge funds are holding shares in ONVO
Organovo Holdings Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
ONVO Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 17.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.2%
Last 30 Days ▲ 6.4%
Last 30 Days ▲ 6.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 100%
Bearish news 100%
Fundamentals
Return on Equity
-378.40%
Trailing 12-Months
Asset Growth
-56.72%
Trailing 12-Months
Company Description
Organovo Holdings Inc
Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds. The company was incorporated in 2007 and is headquartered in Solana Beach, California.
Organovo Holdings (ONVO) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
Nuwellis
―
Sonnet BioTherapeutics Holdings
―
Arcadia Biosciences
―
PainReform
―
Conduit Pharmaceuticals
―
Ownership Overview
24.63% Insiders
13.73% Mutual Funds
11.11% Other Institutional Investors
54.91% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---